| Literature DB >> 11606122 |
A Anderson1, D Belelli, D J Bennett, K I Buchanan, A Casula, A Cooke, H Feilden, D K Gemmell, N M Hamilton, E J Hutchinson, J J Lambert, M S Maidment, R McGuire, P McPhail, S Miller, A Muntoni, J A Peters, F H Sansbury, D Stevenson, H Sundaram.
Abstract
In the search for a novel water-soluble general anesthetic agent the activity of an alpha-amino acid phenolic ester lead, identified from patent literature, was markedly improved. In addition to improving in vivo activity in mice, good in vitro activity at GABA(A) receptors was also conferred. Within the series of compounds good enantioselectivity for both in vitro and in vivo activity was found, supporting a protein-mediated mechanism of action for anesthesia involving allosteric modulation of GABA(A) receptors. alpha-Amino acid phenolic ester 19, as the hydrobromide salt Org 25435, was selected for clinical evaluation since it retained the best overall anesthetic profile coupled with improved stability and water solubility. In the clinic it proved to be an effective intravenous anesthetic in man with rapid onset of and recovery from anesthesia at doses of 3 and 4 mg/kg.Entities:
Mesh：
Substances：
Year: 2001 PMID： 11606122 DOI： 10.1021/jm010903i
Source DB: PubMed Journal: J Med Chem ISSN： 0022-2623 Impact factor: 7.446